Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue European Journal of Cancer Année : 2007

Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).

Résumé

We present the main results of the first population-based cancers survival study gathering all French registry data. Survival data on 205,562 cancer cases diagnosed between 01/01/1989 and 31/12/1997 were analysed. Relative survival was estimated using an excess rate model. The evolution of the excess mortality rate over the follow-up period was graphed. The analysis emphasised the effect of age at diagnosis and its variation with time after diagnosis. For breast and prostate cancers, the age-standardised five-year relative survivals were 84% and 77%, respectively. The corresponding results in men and women were 56% versus 58% for colorectal cancer and 12% versus 16% for lung cancer. For some cancer sites, the excess mortality rate decreased to low values by five years after diagnosis. For most cancer sites, age at diagnosis was a negative prognostic factor but this effect was often limited to the first year after diagnosis.

Dates et versions

inserm-00346768 , version 1 (12-12-2008)

Identifiants

Citer

Nadine Bossard, Michel Velten, Laurent Remontet, Aurélien Belot, Nabil Maarouf, et al.. Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).. European Journal of Cancer, 2007, 43 (1), pp.149-60. ⟨10.1016/j.ejca.2006.07.021⟩. ⟨inserm-00346768⟩
934 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More